Bonzun has agreed to sell all shares in its subsidiary Bonzun Evolve to CBT-based sleep therapy company Learning to Sleep (L2S, listed on First North) for a consideration of 311.2m newly emitted shares in L2S, equivalent to a value of SEK 31.1m or SEK...

While still modest in absolute terms, the Q1 sales growth and deals year-to-date signed affirm the growth story we see emerging in Bonzun, where we expect a doubling of revenues both this year and the next, before positive cash flow in 2025. With the...